Any day ? On what do you base yuor prediction ? How many patients will they have to treat to get the data they needed ? How many more do they need ? How long a treatment peroid do they plan to collect data from ? It will help our trading that much more if we know .
Fresenius is doing a intial program of 100 centers right now. They have been doing this for about 2.5 months. They are collecting data as we speak. Things appear to be going well. If all goes well Fresenius will move toward 500 lcations probably by the end of March 2013.- That is the next major catalyst and the report on the first 100.
They are under limited contract with Amgen for Epogen in the majority of their 2100 domestic centers.But they could break that contract and pay a penalty to Amgen. It's a possibility. Many investors on this board are confused about the once per month shot of Omontys. The patient still has to get weekly dyalisis treatments together with the one a month shot. One shot of Omonteys vs multiple shots of Epogen is still a huge savings and a game changer.
This first 100 dyalisis center test is really a test for the rest of the world to watch and follow.